NCT01405599View on ClinicalTrials.gov

Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Digestive System Disorders
Interventions
DRUG

Ulimorelin

Single dose of 480 micrograms/kg administered as a 30 minute intravenous infusion

Trial Locations (1)

83305

Univerzitna nemocnica Bratislava, nem., Bratislava

Sponsors

Lead Sponsor

Norgine
All Listed Sponsors
lead

Norgine

INDUSTRY